Tag: knee bursitis market segments

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#How Has The Knee Bursitis Market Size Shifted, And What Is the Outlook Through 2034?

The market for knee bursitis has seen robust growth in recent times, with projections indicating a rise from $2.66 billion in 2024 to $2.86 billion in 2025. This equates to a compound annual growth rate (CAGR) of 7.6%. This surge during the historic period can be credited to a number of factors, including an aging population, a rise in engagement in sports and physical activities, advancements in diagnostic processes, improved healthcare accessibility, as well as educational programs aimed at healthcare professionals and patients.

How Much Will the Knee Bursitis Market Be Worth in 2029?

Expectations are high for the knee bursitis market to experience robust growth in the following years. The forecasted growth rate suggests a potential value of $3.79 billion in 2029, representing a compound annual growth rate (CAGR) of 7.3%. This projected growth over the forecast period is largely due to factors such as heightened awareness campaigns focussing on prevention and management, an increase in disposable income, rising healthcare expenditure, in addition to improved awareness and diagnosis of knee bursitis. Key trends for the forecast period take into account advancements in diagnostic technologies, the creation of unique therapies, consistent progress in research and development, and the increasing integration of telemedicine and remote monitoring.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16460&type=smp

Which is the Largest Company in the Knee Bursitis Market?

Major companies operating in the knee bursitis market are Pfizer Inc., Merck & Co. Inc, Bayer AG, Novartis AG, Roche Holding AG, Medtronic plc, Eli Lilly and Company, Amgen Inc, Gilead Sciences Inc., Stryker Corporation, Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, Zimmer Biomet Holdings Inc., DePuy Synthes Inc., Arthrex Inc., Globus Medical Inc., Bioventus LLC, Exactech Inc., Genentech Inc., Conformis Inc., Oncolys BioPharma Inc, Bellicum Pharmaceuticals Inc, Merrimack Pharmaceuticals Inc, 4Med Medical Solutions Inc

What Are the Main Market Drivers in the Knee Bursitis Industry?

The proliferation of bone-related diseases is anticipated to fuel the knee bursitis market’s expansion. Conditions such as osteoporosis, arthritis, and bone cancer fall under bone-related diseases, impacting the skeletal system’s structure, strength, and functionality. Aging populations, sedentary lifestyles, inadequate nutrition, and environmental shifts contribute to the rising prevalence of these diseases. Bone diseases like osteoarthritis and rheumatoid arthritis can trigger knee bursitis by inducing inflammation and overwhelming pressure on the knee bursa, leading to pain, swelling, and decreased joint function. For example, Healthy Bones Australia, a non-profit organization in Australia, projected in September 2022 that in 2022, an estimated 6.2 million individuals over the age of 50 in Australia would suffer from osteoporosis or osteopenia. This estimate is based on the assertion that 22% have osteoporosis and 78% have osteopenia among the 4.74 million Australians with poor bone health. Therefore, the escalating prevalence of bone-related ailments is encouraging the growth of the knee bursitis market. Issues related to the increasing prevalence of diabetic population are predicted to push the growth of the knee bursitis market. Diabetes is a long-term disease in which the body struggles to maintain the right blood sugar levels due to inadequate insulin manufacture or ineffective insulin application. Factors such as sedentary lifestyles, poor food habits, and genetic predispositions contribute to the rise in diabetes cases. Diabetic individuals are prone to knee bursitis due to inflammation brought on by constant pressure on the knees, weakened immune function, or diabetes-related complications. For instance, a June 2024 report from the National Health Service (NHS), a public health organization based in the UK, noted a significant increase in people diagnosed with pre-diabetes – 3,615,330 in 2023, up from 3,065,825 in 2022, representing an 18% increase. Therefore, the growing diabetic population is pushing the knee bursitis market’s growth.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=16460&type=smp

How Is the Knee Bursitis Market Segments Structured?

The knee bursitis market covered in this report is segmented –

1) By Diagnosis: Imaging Test, Other Diagnosis Tests

2) By Treatment: Medication, Therapy, Surgery, Other Treatments

3) By End User: Hospitals And Clinics, Diagnostic Centers, Research Centers, Academic Institutes, Other End Users

Subsegments:

1) By Imaging Test: X-Ray, MRI (Magnetic Resonance Imaging), Ultrasound

2) By Other Diagnosis Tests: Physical Examination, Aspiration Of Joint Fluid, Blood Tests

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/knee-bursitis-global-market-report

Which Global Regions Offer the Highest Growth in the Knee Bursitis Market?

North America was the largest region in the knee bursitis market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the knee bursitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16460

This Report Delivers Insight On:

1. How big is the knee bursitis market, and how is it changing globally?

2. Who are the major companies in the knee bursitis market, and how are they performing?

3. What are the key opportunities and risks in the knee bursitis market right now?

4. Which products or customer segments are growing the most in the knee bursitis market?

5. What factors are helping or slowing down the growth of the knee bursitis market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the knee bursitis industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

How Fast Is The Knee Bursitis Market Expected to Grow Between 2025 And 2029?

The market size for knee bursitis has seen considerable growth in the past few years. The market, which is projected to increase from $2.66 billion in 2024 to $2.86 billion in 2025, is expected to grow at a compound annual growth rate (CAGR) of 7.6%. The growth seen in the previous period can be credited to factors like an aging population, more individual involvement in sports and physical activities, bettered diagnostic methods, enhanced healthcare services accessibility, and educational initiatives aimed at healthcare professionals and patients.

The market for knee bursitis is anticipated to witness robust expansion in the forthcoming years. The market value is forecasted to reach $3.79 billion by 2029, with a compound annual growth rate (CAGR) of 7.3%. Factors contributing to this increase during the projected period are heightened awareness initiatives on prevention and management, a rise in disposable income, increased healthcare spending, and improved recognition and diagnosis of knee bursitis. Noteworthy trends in the forecasted period include progress in diagnostic methods, the introduction of new treatments, enhancements in research and development activities, and the emergence of telemedicine and remote monitoring.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16460&type=smp

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Knee Bursitis Market?

The escalating occurrence of diseases related to bones is anticipated to fuel the knee bursitis market’s expansion in the future. Conditions such as osteoporosis, arthritis, and bone cancer fall under the category of bone-related diseases, which affect the structure, strength, and functioning of the skeletal system. Aging populations, sedentary living conditions, poor nutritional intake, and environmental factors contribute to the escalating prevalence of bone-related illnesses. Illnesses like osteoarthritis and rheumatoid arthritis can trigger knee bursitis by instigating inflammation and added pressure to the knee bursa, leading to pain, swelling, and a decline in joint function. A projection by Healthy Bones Australia in September 2022 stated that there are an estimated 6.2 million individuals aged 50 and above in Australia suffering from osteoporosis or osteopenia in 2022. This figure is derived from facts stating that 22% have osteoporosis and 78% have osteopenia among 4.74 million Australians with poor bone health. Hence, the escalating prevalence of bone-related diseases is contributing to the growth of the knee bursitis market. An expanding diabetic population is set to spur the knee bursitis market’s growth in the future. Diabetes, a chronic illness where the body is unable to regulate blood sugar levels correctly due to insufficient insulin generation or inefficient usage of insulin, is increasing due to factors like sedentary lifestyles, unhealthy dietary consumption, and genetic predispositions. Diabetic patients are susceptible to developing knee bursitis due to prolonged knee pressure, compromised immune function, and complications relating to diabetes. A report by the National Health Service (NHS) in June 2024 indicated an 18% increase in the number of people registering as pre-diabetic in 2023, up to 3,615,330 from 3,065,825 in 2022. Therefore, the rise in the diabetic population is fuelling the knee bursitis market’s growth.

Which Segments in the Knee Bursitis Offer the Most Growth?

The knee bursitis market covered in this report is segmented –

1) By Diagnosis: Imaging Test, Other Diagnosis Tests

2) By Treatment: Medication, Therapy, Surgery, Other Treatments

3) By End User: Hospitals And Clinics, Diagnostic Centers, Research Centers, Academic Institutes, Other End Users

Subsegments:

1) By Imaging Test: X-Ray, MRI (Magnetic Resonance Imaging), Ultrasound

2) By Other Diagnosis Tests: Physical Examination, Aspiration Of Joint Fluid, Blood Tests

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=16460&type=smp

Which Areas Are Leading Regions in the Knee Bursitis Market Expansion Across the Globe?

North America was the largest region in the knee bursitis market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the knee bursitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

View the full report here:

https://www.thebusinessresearchcompany.com/report/knee-bursitis-global-market-report

What Are the Key Elements That Define the Knee Bursitis Market?

Knee bursitis refers to the inflammation of one or more bursae, the small fluid-filled sacs near the knee joint. These bursae cushion and reduce friction between tissues, such as between bones and tendons or muscles. When inflamed, they cause pain, swelling, and restricted movement in the knee.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16460

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the knee bursitis industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

How Fast Is The Knee Bursitis Market Expected to Grow Between 2025 And 2029?

The market size for knee bursitis has seen considerable growth in the past few years. The market, which is projected to increase from $2.66 billion in 2024 to $2.86 billion in 2025, is expected to grow at a compound annual growth rate (CAGR) of 7.6%. The growth seen in the previous period can be credited to factors like an aging population, more individual involvement in sports and physical activities, bettered diagnostic methods, enhanced healthcare services accessibility, and educational initiatives aimed at healthcare professionals and patients.

The market for knee bursitis is anticipated to witness robust expansion in the forthcoming years. The market value is forecasted to reach $3.79 billion by 2029, with a compound annual growth rate (CAGR) of 7.3%. Factors contributing to this increase during the projected period are heightened awareness initiatives on prevention and management, a rise in disposable income, increased healthcare spending, and improved recognition and diagnosis of knee bursitis. Noteworthy trends in the forecasted period include progress in diagnostic methods, the introduction of new treatments, enhancements in research and development activities, and the emergence of telemedicine and remote monitoring.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16460&type=smp

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Knee Bursitis Market?

The escalating occurrence of diseases related to bones is anticipated to fuel the knee bursitis market’s expansion in the future. Conditions such as osteoporosis, arthritis, and bone cancer fall under the category of bone-related diseases, which affect the structure, strength, and functioning of the skeletal system. Aging populations, sedentary living conditions, poor nutritional intake, and environmental factors contribute to the escalating prevalence of bone-related illnesses. Illnesses like osteoarthritis and rheumatoid arthritis can trigger knee bursitis by instigating inflammation and added pressure to the knee bursa, leading to pain, swelling, and a decline in joint function. A projection by Healthy Bones Australia in September 2022 stated that there are an estimated 6.2 million individuals aged 50 and above in Australia suffering from osteoporosis or osteopenia in 2022. This figure is derived from facts stating that 22% have osteoporosis and 78% have osteopenia among 4.74 million Australians with poor bone health. Hence, the escalating prevalence of bone-related diseases is contributing to the growth of the knee bursitis market. An expanding diabetic population is set to spur the knee bursitis market’s growth in the future. Diabetes, a chronic illness where the body is unable to regulate blood sugar levels correctly due to insufficient insulin generation or inefficient usage of insulin, is increasing due to factors like sedentary lifestyles, unhealthy dietary consumption, and genetic predispositions. Diabetic patients are susceptible to developing knee bursitis due to prolonged knee pressure, compromised immune function, and complications relating to diabetes. A report by the National Health Service (NHS) in June 2024 indicated an 18% increase in the number of people registering as pre-diabetic in 2023, up to 3,615,330 from 3,065,825 in 2022. Therefore, the rise in the diabetic population is fuelling the knee bursitis market’s growth.

Which Segments in the Knee Bursitis Offer the Most Growth?

The knee bursitis market covered in this report is segmented –

1) By Diagnosis: Imaging Test, Other Diagnosis Tests

2) By Treatment: Medication, Therapy, Surgery, Other Treatments

3) By End User: Hospitals And Clinics, Diagnostic Centers, Research Centers, Academic Institutes, Other End Users

Subsegments:

1) By Imaging Test: X-Ray, MRI (Magnetic Resonance Imaging), Ultrasound

2) By Other Diagnosis Tests: Physical Examination, Aspiration Of Joint Fluid, Blood Tests

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=16460&type=smp

Which Areas Are Leading Regions in the Knee Bursitis Market Expansion Across the Globe?

North America was the largest region in the knee bursitis market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the knee bursitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

View the full report here:

https://www.thebusinessresearchcompany.com/report/knee-bursitis-global-market-report

What Are the Key Elements That Define the Knee Bursitis Market?

Knee bursitis refers to the inflammation of one or more bursae, the small fluid-filled sacs near the knee joint. These bursae cushion and reduce friction between tissues, such as between bones and tendons or muscles. When inflamed, they cause pain, swelling, and restricted movement in the knee.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16460

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Knee Bursitis Market?

The knee bursitis market is predicted to grow due to the escalating occurrence of diseases related to bones. Such bone-related ailments include osteoporosis, arthritis, and bone cancer, impacting the skeletal system’s design, robustness, and function. The rise in these conditions is credited to elements such as growing elderly population, inactive way of life, inadequate nutrition, and changing environments. Diseases related to bones, such as osteoarthritis and rheumatoid arthritis, might result in knee bursitis by provoking inflammation and excessive strain on the knee bursa. This inflammation leads to pain, swelling, and a diminished joint function. A report by Healthy Bones Australia, a non-profit organization in Australia, projected in September 2022 that an estimate of 6.2 million individuals aged 50 and up in Australia would be suffering from osteoporosis or osteopenia in 2022. This estimate is based on the fact that 22% have osteoporosis and 78% have osteopenia among the 4.74 million Australians with poor bone health. Therefore, the increasing incidence of bone-related health conditions is propelling the growth of the knee bursitis market. The growth of the knee bursitis market is anticipated to be fueled by the rising diabetic population. Diabetes, which is a chronic disease where the body’s inability to regulate blood sugar levels, is often caused by insufficient insulin production or ineffective use of insulin. The rise in diabetic cases is attributed to factors such as inactive lifestyles, unhealthy dietary habits, and genetic predispositions. Diabetes patients can develop knee bursitis due to inflammation caused by prolonged pressure on the knees, impaired immune function, or complications related to diabetes. A report by the National Health Service (NHS) showed that as of June 2024, the number of people registered with pre-diabetes increased to 3,615,330 in 2023, a rise of 18% from 3,065,825 in 2022. Hence, the increasing diabetic population is propelling the growth of the knee bursitis market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16460&type=smp

How Has the Knee Bursitis Market Evolved in Recent Years, and What are the Growth Projections for the Forecast Period?

There has been significant growth in the market size for knee bursitis in the past years. The market is projected to expand from $2.66 billion in 2024 to $2.86 billion in 2025, with a compound annual growth rate (CAGR) of 7.6%. The market expansion during the historic period can be credited to factors such as the aging population, a rise in engagement in sports and physical activities, advancements in diagnostic methods, better access to healthcare services, and educational initiatives for both healthcare providers and patients.

We anticipate substantial expansion in the knee bursitis market in the upcoming years. By 2029, it’s projected to soar to $3.79 billion with a compound annual growth rate (CAGR) of 7.3%. The forecast period’s escalation can be linked to heightened consciousness campaigns around prevention and administration, increased disposable income, upticks in healthcare expenditure, and a surge in recognition and diagnosis of knee bursitis. Major movements expected during the forecast period cover advancements in diagnostic methods, the emergence of new therapies, progress in research and development undertakings, as well as the rise of telemedicine and remote tracking.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16460

Who Are the Top Companies Driving Innovation and Growth in theKnee Bursitis Market?

Major companies operating in the knee bursitis market are Pfizer Inc., Merck & Co. Inc, Bayer AG, Novartis AG, Roche Holding AG, Medtronic plc, Eli Lilly and Company, Amgen Inc, Gilead Sciences Inc., Stryker Corporation, Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, Zimmer Biomet Holdings Inc., DePuy Synthes Inc., Arthrex Inc., Globus Medical Inc., Bioventus LLC, Exactech Inc., Genentech Inc., Conformis Inc., Oncolys BioPharma Inc, Bellicum Pharmaceuticals Inc, Merrimack Pharmaceuticals Inc, 4Med Medical Solutions Inc

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/knee-bursitis-global-market-report

Which Key Market Segments Comprise the Knee Bursitis Market and Drive Its Revenue Growth?

The knee bursitis market covered in this report is segmented –

1) By Diagnosis: Imaging Test, Other Diagnosis Tests

2) By Treatment: Medication, Therapy, Surgery, Other Treatments

3) By End User: Hospitals And Clinics, Diagnostic Centers, Research Centers, Academic Institutes, Other End Users

Subsegments:

1) By Imaging Test: X-Ray, MRI (Magnetic Resonance Imaging), Ultrasound

2) By Other Diagnosis Tests: Physical Examination, Aspiration Of Joint Fluid, Blood Tests

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=16460&type=smp

Which Regions Are Emerging as Leaders in the Knee Bursitis Market?

North America was the largest region in the knee bursitis market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the knee bursitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Knee Bursitis Market 2025, By The Business Research Company:

Medical Devices Reimbursement Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/medical-devices-reimbursement-global-market-report

Healthcare Reimbursement Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/healthcare-reimbursement-global-market-report

1, 4 Butanediol Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/1-4-butanediol-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

How has the knee bursitis market size evolved in recent years?

The market for knee bursitis has seen significant growth in the recent past. The market, which was valued at $2.66 billion in 2024, is projected to increase to $2.86 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.6%. The substantial growth during the historical period is attributed to factors such as an ageing population, heightened engagement in sports and physical routines, advancements in diagnostic strategies, better healthcare access, and educational schemes for health practitioners and patients.

What are the predictions for the knee bursitis market size in the coming years?

The market size for knee bursitis is predicted to notably expand in the coming years, with predictions suggesting it will reach $3.79 billion by 2029, growing at a compound annual growth rate (CAGR) of 7.3%. This growth during the forecast period is believed to be a result of growing awareness initiatives concerning prevention and management, increased discretionary income, escalated spending on healthcare, and a rise in awareness and diagnosis of knee bursitis. The forecast period is also expected to see major trends such as improved diagnostic methodologies, the creation of unique therapies, progression in research and development efforts, and the emergence of telemedicine and remote patient monitoring.

Get your knee bursitis market report here!

https://www.thebusinessresearchcompany.com/report/knee-bursitis-global-market-report

What key factors are fueling the growth of the knee bursitis market?

The escalating rates of diseases linked to the bones are anticipated to boost the expansion of the knee bursitis market. Disorders of the bone, such as osteoporosis, arthritis, and bone cancer, interfere with the structure, strength, and function of the skeletal system. The rising rates of these bone-related diseases are due to factors like aging populations, inactive lifestyles, poor nutrition, and environmental shifts. Bone disorders, including osteoarthritis and rheumatoid arthritis, can trigger knee bursitis by promoting inflammation and overpressure on the knee bursa, leading to pain, swelling, and lessened joint functioning. For example, Healthy Bones Australia, a non-profit organization based in Australia, projected in September 2022 that 6.2 million individuals aged 50 and above are estimated to have osteoporosis or osteopenia in 2022. This estimate is based on 22% having osteoporosis and 78% having osteopenia among 4.74 million Australians with poor bone health. Thus, the escalating prevalence of bone-related conditions is prompting the expansion of the knee bursitis market. The knee bursitis market is expected to benefit from the growing diabetic population. Diabetes, a persistent condition wherein the body can’t regulate blood sugar levels properly due to inadequate insulin production or ineffective insulin use, is rising due to factors such as inactive lifestyles, unhealthy diet, and genetic predispositions. Diabetic individuals are at risk of developing knee bursitis due to prolonged pressure on the knees, weakened immune systems, or complications associated with diabetes. A report published by the UK-based public health organization National Health Service (NHS) in June 2024 highlighted that the number of individuals preregistered with diabetes rose by 18% to 3,615,330 in 2023, from 3,065,825 in 2022. Therefore, the mounting diabetic population is contributing to the proliferation of knee bursitis market.

How is the global knee bursitis market divided into key segments?

The knee bursitis market covered in this report is segmented –

1) By Diagnosis: Imaging Test, Other Diagnosis Tests

2) By Treatment: Medication, Therapy, Surgery, Other Treatments

3) By End User: Hospitals And Clinics, Diagnostic Centers, Research Centers, Academic Institutes, Other End Users

Subsegments:

1) By Imaging Test: X-Ray, MRI (Magnetic Resonance Imaging), Ultrasound

2) By Other Diagnosis Tests: Physical Examination, Aspiration Of Joint Fluid, Blood Tests

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16460&type=smp

Who are the key firms paving the way for growth in the knee bursitis market?

Major companies operating in the knee bursitis market are Pfizer Inc., Merck & Co. Inc, Bayer AG, Novartis AG, Roche Holding AG, Medtronic plc, Eli Lilly and Company, Amgen Inc, Gilead Sciences Inc., Stryker Corporation, Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, Zimmer Biomet Holdings Inc., DePuy Synthes Inc., Arthrex Inc., Globus Medical Inc., Bioventus LLC, Exactech Inc., Genentech Inc., Conformis Inc., Oncolys BioPharma Inc, Bellicum Pharmaceuticals Inc, Merrimack Pharmaceuticals Inc, 4Med Medical Solutions Inc

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16460

What regions are contributing significantly to the growth of the knee bursitis market?

North America was the largest region in the knee bursitis market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the knee bursitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Medical Devices Reimbursement Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/medical-devices-reimbursement-global-market-report

Healthcare Reimbursement Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/healthcare-reimbursement-global-market-report

1, 4 Butanediol Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/1-4-butanediol-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

2024-2033 Knee Bursitis Market Growth Rate: What’s the Forecast?

The knee bursitis market has shown strong growth in recent years, anticipated to grow from $2.48 billion in 2023 to $2.66 billion in 2024, with a CAGR of 7.3%. Factors driving this growth include an aging population, increased participation in sports and physical activities, improved diagnostic techniques, better access to healthcare services, and educational programs for healthcare professionals and patients.

The knee bursitis market is expected to grow significantly, reaching $3.54 billion by 2028 at a CAGR of 7.4%. Contributing factors include awareness campaigns on prevention, rising disposable income, increased healthcare spending, and improved diagnosis. Major trends include advancements in diagnostic techniques, novel therapy developments, increased R&D activities, and telemedicine adoption.

Claim Your Free Sample of the Global Knee Bursitis Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=16460&type=smp

What Drivers Are Accelerating the Growth of the Knee Bursitis Market?

The rising occurrence of bone-related diseases is expected to drive growth in the knee bursitis market. Conditions like osteoporosis, arthritis, and bone cancer compromise skeletal health and functionality. This increase is linked to aging populations, sedentary lifestyles, and poor nutrition. Bone diseases can lead to knee bursitis due to inflammation and pressure on the knee bursa. For example, in September 2022, Healthy Bones Australia projected that 6.2 million Australians over 50 suffer from osteoporosis or osteopenia. Therefore, the prevalence of bone-related diseases is fueling the knee bursitis market.

What Key Segments Can Be Identified in the Knee Bursitis Market?

1) By Diagnosis: Imaging Test, Other Diagnosis Tests

2) By Treatment: Medication, Therapy, Surgery, Other Treatments

3) By End User: Hospitals And Clinics, Diagnostic Centers, Research Centers, Academic Institutes, Other End Users

Order Now for Fast Delivery of Your Knee Bursitis Market Report!

https://www.thebusinessresearchcompany.com/report/knee-bursitis-global-market-report

What Regions Are Steering Growth in the Knee Bursitis Sector?

North America was the largest region in the knee bursitis market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the knee bursitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Knee Bursitis Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the knee bursitis market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Knee Bursitis Market Include

1. Knee Bursitis Market Executive Summary

2. Knee Bursitis Market Segments

3. Knee Bursitis Market Size And Template Market Growth Rate

4. Key Knee Bursitis Market Trends

5. Major Knee Bursitis Market Drivers

……

25. Key Mergers And Acquisitions In The Knee Bursitis Market

26. Top Knee Bursitis Companies

27. Knee Bursitis Market Opportunities And Strategies

28. Knee Bursitis Market, Conclusions And Recommendations

29. Appendix

Discover Related Reports by The Business Research Company:

Knee Implants Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/knee-implants-global-market-report

Total Hip and Knee Replacements Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/total-hip-and-knee-replacements-global-market-report

Healthcare Reimbursement Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/healthcare-reimbursement-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

The Business Research Company’s market reports offer an in-depth analysis on the market’s growth potential, major drivers, key trends and more.

Market Overview

• Current Market Size:
  • The knee bursitis market was valued at $2.48 billion in 2023. It is projected to grow to $2.66 billion in 2024, reflecting a compound annual growth rate (CAGR) of 7.3%.
• Future Projections:
  • By 2028, the market is expected to reach $3.54 billion, with a CAGR of 7.4%.

Key Drivers of Market Growth

• Aging Population:
  • An older demographic is more susceptible to knee bursitis due to age-related wear and tear.
• Increased Physical Activity:
  • More people participating in sports and physical activities is leading to higher instances of knee injuries, including bursitis.
• Improved Diagnostics and Healthcare Access:
  • Better diagnostic techniques and enhanced access to healthcare services have led to increased detection and treatment of knee bursitis.
• Education Programs:
  • Training and education for healthcare professionals and patients have improved understanding and management of knee bursitis.

Read More On The Knee Bursitis Market Report 2024 – https://www.thebusinessresearchcompany.com/report/knee-bursitis-global-market-report

Future Growth Drivers

• Awareness Campaigns:
  • Increased public awareness about prevention and management of knee bursitis is expected to boost market growth.
• Rising Disposable Income and Healthcare Expenditure:
  • Growing income levels and higher spending on healthcare contribute to increased treatment access and affordability.
• Advancements in Diagnosis and Treatment:
  • Continuous improvements in diagnostic techniques and novel therapies are anticipated to drive market expansion.

Impact of Bone-Related Diseases

• Bone-Related Disease Prevalence:
  • Conditions like osteoporosis, arthritis, and bone cancer affect the skeletal system, leading to increased incidences of knee bursitis.
• Factors Contributing to Bone-Related Diseases:
  • Aging, sedentary lifestyles, poor nutrition, and environmental changes are key factors contributing to these conditions.
• Impact on Knee Bursitis:
  • Diseases such as osteoarthritis and rheumatoid arthritis cause inflammation and pressure on the knee bursa, leading to pain and reduced joint function.
• Statistics:
  • In September 2022, Healthy Bones Australia reported that 6.2 million individuals aged 50 and above were affected by osteoporosis or osteopenia, highlighting the prevalence of bone-related diseases.

Market Segmentation

• By Diagnosis:
  • Imaging Tests
  • Other Diagnostic Tests
• By Treatment:
  • Medication
  • Therapy
  • Surgery
  • Other Treatments
• By End User:
  • Hospitals and Clinics
  • Diagnostic Centers
  • Research Centers
  • Academic Institutes
  • Other End Users

Regional Insights

• North America:
  • In 2023, North America was the largest market for knee bursitis, driven by advanced healthcare infrastructure and high diagnosis rates.
• Asia-Pacific:
  • Expected to be the fastest-growing region, due to increasing healthcare investments and rising awareness about knee bursitis.

Conclusion

• The knee bursitis market is experiencing robust growth, driven by demographic changes, increased physical activity, and advancements in healthcare.
• Rising awareness, improvements in diagnostic and treatment methods, and the growing prevalence of bone-related diseases are key factors contributing to market expansion.
• With North America leading the market and Asia-Pacific emerging as a fast-growing region, the knee bursitis market is poised for continued growth and innovation in the coming years.

Request for A Sample Of The Global Knee Bursitis Market Report:
https://www.thebusinessresearchcompany.com/sample_request?id=16460&type=smp